TITLE

Pharmacodynamic studies on the central mode of action of S-adenosyl-L-methionine (SAMe) infusions in elderly subjects, utilizing EEG mapping and psychometry

AUTHOR(S)
Saletu, B.; Anderer, P.; Linzmayer, L.; Semlitsch, H. V.; Lindeck-Pozza, E.; Assandri, A.; di Padova, C.; Saletu-Zyhlarz, G. M.
PUB. DATE
December 2002
SOURCE
Journal of Neural Transmission;Dec2002, Vol. 109 Issue 12, p1505
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Summary. In a double-blind, placebo-controlled cross-over study, the acute and subacute effects of S-adenosyl-L-methionine (SAMe), or ademetionine, on brain function and behavior of 10 elderly normal healthy volunteers (5 males and 5 females, aged 56–71 years, mean: 59.3 years) were investigated by means of EEG mapping and psychometry. In random order they received infusions of 800 mg SAMe and placebo, administered over 30 minutes for 7 days, with a wash-out period of 3 weeks in between. EEG recordings and psychometric tests were carried out 0, 1, 3 and 6 hours after drug administration on days 1 and 7. Multivariate analysis based on MANOVA/Hotelling T2 tests demonstrated significant central effects of SAMe as compared with placebo after acute, subacute and superimposed drug administration. Acute SAMe-induced changes were characterized by a decrease in total power, an increase in absolute delta and a decrease in absolute alpha power, further by an increase in relative delta and a decrease in relative alpha power, a slowing of the delta/theta centroid as well as a slowing of the centroid of the total power spectrum. These changes are typical of classical antidepressants of the thymoleptic type such as imipramine and amitriptyline. After one week of daily infusions there was a marked increase in total power, reminiscent of nootropic drug effects. One additional superimposed dosage mitigated these effects in the direction of an antidepressant profile, with the inter-drug differences waning in the 6th hour. Our pharmaco-EEG findings suggest both inhibitory and excitatory drug effects underlying the antidepressant properties of SAMe well-documented in clinical trials. Psychometric tests concerning noopsychic and thymopsychic measures as well as critical flicker frequency generally demonstrated a lack of differences between SAMe and placebo, which again reflects a good tolerability of the drug in elderly subjects.
ACCESSION #
15395005

 

Related Articles

  • Assessing clinically relevant cognitive decline: preliminary data on a new method. Isella, V.; Atzeni, L.; Iurlaro, S.; Villa, M. L.; Russo, A.; Forapani, E.; Frattola, L.; Appollonio, I. M. // Neurological Sciences;Nov2003, Vol. 24 Issue 4, p236 

    Physiological age-related cognitive decline, practice effect and regression to the mean may interfere with the interpretation of psychometric changes between subsequent neuropsychological evaluations. The standardized regression- based (SRB) change score allows investigators to define...

  • Driving Cessation in Older Adults With Dementia of the Alzheimer's Type. Carr, David B.; Shead, Veronica; Storandt, Martha // Gerontologist;Dec2005, Vol. 45 Issue 6, p824 

    The psychometric profile of 143 drivers with dementia who stopped driving did not differ from that of 58 individuals with dementia of similar severity who still drove. The reasons given for driving cessation by drivers with dementia as reported by a collateral source are reported.

  • Aging brain seminar offers advice, tips. Binder, Sarah // Corridor Business Journal;2/4/2013, Vol. 9 Issue 28, p20 

    The article presents tips related to brain health for aging people. It states that people who perform cardiovascular exercises on a regular basis are less likely to develop dementia while diet rich in antioxidants can help to improve brain health in old people. It further states that people...

  • Researchers divided over Alzheimer's and aluminum. Brown, Phyllida // New Scientist;7/21/90, Vol. 127 Issue 1726, p21 

    Reports on the controversy between two groups researching Alzheimers disease. Medical Research Council (MRC) claims high aluminum concentrations in plaque samples; Oxford researchers found less than 20 percent in their study; Analysis of brain tissue has major methodological problems; Tangles...

  • smarten up! Tweed, Vera // Better Nutrition;Jun2009, Vol. 71 Issue 6, p22 

    The article presents information on dietary supplement Cognizin. Numerous studies have found that Cognizin improves brain function in elderly people, but more recently, the supplement was tested on 16 healthy, middle-aged men and women. The new study found that the supplement increased levels of...

  • Development, Reliability, and Validity of the Expectations Regarding Aging (ERA-38) Survey. Sarkisian, Catherine A.; Hays, Ron D.; Berry, Sandra; Mangione, Carol M. // Gerontologist;Aug2002, Vol. 42 Issue 4, p534 

    Presents information on a study which developed an instrument to measure older adults' expectations regarding aging. Design and methodology; Results and discussion.

  • Comparing Approaches for Categorizing Measure Reliability in the Assessment of Anxiety in Older Adults. Therrien, Zoé; Hunsley, John // Administration & Policy in Mental Health & Mental Health Service;Sep2014, Vol. 41 Issue 5, p615 

    A systematic review of the anxiety measures most commonly used with older adults found that most are developed for a younger population and lacked sufficient evidence of their psychometric properties when used with an older population. As researchers and clinicians need a fast way to judge...

  • Antidepressants in older people. Hickie, Ian B. // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;8/13/2011, Vol. 343 Issue 7819, p329 

    No abstract available.

  • Older Patients Not Always Helped by Antidepressants.  // Nutrition Health Review: The Consumer's Medical Journal;2002, Issue 84, p6 

    Reports that older patients get little benefits from antidepressants which concentrate on the brain chemical serotonin. Effectiveness of antidepressants fluoxetine and sertaline in treating depression; Possible use of positron emission tomography to identify persons benefitting from drugs...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics